JP2025503188A5 - - Google Patents
Info
- Publication number
- JP2025503188A5 JP2025503188A5 JP2024544471A JP2024544471A JP2025503188A5 JP 2025503188 A5 JP2025503188 A5 JP 2025503188A5 JP 2024544471 A JP2024544471 A JP 2024544471A JP 2024544471 A JP2024544471 A JP 2024544471A JP 2025503188 A5 JP2025503188 A5 JP 2025503188A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- amino acid
- acid substitutions
- oncolytic virus
- site
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210094869.1 | 2022-01-26 | ||
| CN202210094869.1A CN114540316B (zh) | 2022-01-26 | 2022-01-26 | 溶瘤病毒及其应用 |
| PCT/CN2023/071375 WO2023143023A1 (zh) | 2022-01-26 | 2023-01-09 | 溶瘤病毒及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503188A JP2025503188A (ja) | 2025-01-30 |
| JP2025503188A5 true JP2025503188A5 (enExample) | 2026-01-08 |
Family
ID=81673943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544471A Pending JP2025503188A (ja) | 2022-01-26 | 2023-01-09 | 腫瘍溶解性ウイルス及びその用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240424040A1 (enExample) |
| EP (1) | EP4471132A4 (enExample) |
| JP (1) | JP2025503188A (enExample) |
| KR (1) | KR20240137069A (enExample) |
| CN (6) | CN119709650A (enExample) |
| AU (1) | AU2023210771A1 (enExample) |
| CA (1) | CA3243385A1 (enExample) |
| WO (1) | WO2023143023A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119709650A (zh) * | 2022-01-26 | 2025-03-28 | 上海荣瑞医药科技有限公司 | 溶瘤病毒及其应用 |
| CN117402837A (zh) * | 2022-07-14 | 2024-01-16 | 上海荣瑞医药科技有限公司 | 一种重组溶瘤病毒及其应用 |
| CN117402836A (zh) * | 2022-07-14 | 2024-01-16 | 上海荣瑞医药科技有限公司 | 重组溶瘤病毒及其应用 |
| CN116350759A (zh) * | 2023-03-30 | 2023-06-30 | 上海荣瑞医药科技有限公司 | 溶瘤病毒疫苗和免疫细胞联合治疗肿瘤的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1769433B (zh) * | 2004-11-04 | 2011-03-16 | 张庆勇 | 重组水疱性口炎病毒及其应用 |
| RU2010124788A (ru) * | 2007-12-21 | 2012-01-27 | Ваейт ЭлЭлСи (US) | Генетически модифицированный ослабленный вирус везикулярного стоматита, композиции и способы их применения |
| DE102008050860A1 (de) * | 2008-10-08 | 2010-04-15 | Dorothee Von Laer | LCMV-GP-VSV-Pseudotypvektoren und tumorinfiltrierende Virenproduzentenzellen zur Therapie von Tumoren |
| AR097648A1 (es) | 2013-09-13 | 2016-04-06 | Amgen Inc | Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide |
| CN105087645A (zh) * | 2015-08-04 | 2015-11-25 | 上海交通大学 | M蛋白三氨基酸位点突变的猪用vsv病毒载体构建和应用 |
| EP3246410A1 (en) * | 2016-05-19 | 2017-11-22 | Klinikum rechts der Isar der Technischen Universität München | Vsv/ndv hybrid viruses for oncolytic therapy of cancer |
| CN110305198B (zh) * | 2018-03-27 | 2021-01-29 | 睿丰康生物医药科技(浙江)有限公司 | 一种溶瘤棒状病毒减毒株及其在肿瘤治疗中的应用 |
| CN110819657B (zh) * | 2018-08-10 | 2021-11-19 | 睿丰康生物医药科技(浙江)有限公司 | 一种减毒棒状病毒的制备方法及应用 |
| TWI894135B (zh) * | 2019-01-25 | 2025-08-21 | 德商百靈佳殷格翰國際股份有限公司 | 編碼ccl21之重組棒狀病毒 |
| CN111467489B (zh) * | 2020-05-12 | 2022-06-03 | 上海荣瑞医药科技有限公司 | 一种治疗肿瘤的药物 |
| CN111286493B (zh) * | 2020-05-12 | 2020-10-27 | 上海荣瑞医药科技有限公司 | 一种溶瘤病毒疫苗及其与免疫细胞联合治疗肿瘤的药物 |
| CN113832114A (zh) * | 2020-06-23 | 2021-12-24 | 南京大学 | 一种新型溶瘤腺病毒EM/VSV-G Ad5-P及其在制备抗肿瘤药物中的应用 |
| CN119709650A (zh) * | 2022-01-26 | 2025-03-28 | 上海荣瑞医药科技有限公司 | 溶瘤病毒及其应用 |
| CN117402837A (zh) * | 2022-07-14 | 2024-01-16 | 上海荣瑞医药科技有限公司 | 一种重组溶瘤病毒及其应用 |
| CN117402836A (zh) * | 2022-07-14 | 2024-01-16 | 上海荣瑞医药科技有限公司 | 重组溶瘤病毒及其应用 |
-
2022
- 2022-01-26 CN CN202411986086.XA patent/CN119709650A/zh active Pending
- 2022-01-26 CN CN202411986368.XA patent/CN119709652A/zh active Pending
- 2022-01-26 CN CN202411986145.3A patent/CN119709651A/zh active Pending
- 2022-01-26 CN CN202210094869.1A patent/CN114540316B/zh active Active
- 2022-01-26 CN CN202411986002.2A patent/CN119709649A/zh active Pending
- 2022-01-26 CN CN202411986426.9A patent/CN119736261A/zh active Pending
-
2023
- 2023-01-09 EP EP23745906.0A patent/EP4471132A4/en active Pending
- 2023-01-09 CA CA3243385A patent/CA3243385A1/en active Pending
- 2023-01-09 JP JP2024544471A patent/JP2025503188A/ja active Pending
- 2023-01-09 AU AU2023210771A patent/AU2023210771A1/en active Pending
- 2023-01-09 KR KR1020247028113A patent/KR20240137069A/ko active Pending
- 2023-01-09 WO PCT/CN2023/071375 patent/WO2023143023A1/zh not_active Ceased
-
2024
- 2024-07-26 US US18/785,273 patent/US20240424040A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230190838A1 (en) | Oncolytic virus in combination with immune checkpoint inhibitor for treating tumors | |
| JP2025503188A5 (enExample) | ||
| US20240424040A1 (en) | Oncolytic virus and use thereof | |
| KR102566552B1 (ko) | 종양 치료용 바이러스 | |
| AU2019254948B2 (en) | Coxsackie virus B for treating tumors | |
| CN109568350B (zh) | 一种用于治疗肿瘤的柯萨奇病毒 | |
| AU2018320550B2 (en) | Echovirus for treating tumor | |
| EP2948157B1 (en) | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (mv-deltac virus) in cancer therapy | |
| US20240226209A1 (en) | Oncolytic virus and use thereof | |
| HK40105653A (en) | Oncolytic virus and use thereof | |
| CA3070628C (en) | Enterovirus d68 (ev-d68) for treatment of tumor | |
| WO2018120496A1 (zh) | 重组溶瘤流感病毒制备方法和应用 |